Trial intelligence / Profile preview

DESTINaTE-AHF: Natriuresis-Guided Diuretic Therapy in Acute Heart Failure

NCT07804654Completed

Sponsor
Universiti Teknologi MARA
Start
Jan 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Randomised, open-label trial of furosemide in Acute Heart Failure (AHF) (3 arms), sponsored by Universiti Teknologi MARA. Primary endpoints: 24-Hour Urinary Sodium Excretion, 24-Hour Urine Volume and 1 more. Started Jan 2026; status: completed.

02

Drugs

furosemide
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT07804654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07804654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call